• FXR–KLF11 Signaling in Contrast-Induced AKI

  2026-09-29

  A 2026 study identifies an FXR–KLF11 transcriptional axis that protects against contrast-induced acute kidney injury by suppressing JAK2/STAT3 signaling. Using mouse, HK-2 cell, transcriptomic, promoter-reporter, ChIP, and genetic experiments, the work positions CDCA as a mechanistic probe for renal injury prevention while leaving clinical translation unresolved.

• DRB Workflows for Transcriptional Elongation

  2026-09-29

  DRB provides a practical perturbation tool for studying RNA polymerase II output, CTD kinase activity, HIV transcription inhibition, and selected antiviral phenotypes. This guide connects those applications with the YTHDF1 phase-separation study while separating validated product uses from hypothesis-generating experiments in stem-cell fate research.

• Nitrocefin for β-Lactamase Activity Assays

  2026-09-28

  Nitrocefin converts β-lactam hydrolysis into a rapid yellow-to-red readout for enzyme characterization, resistance profiling, and inhibitor screening. This guide connects practical assay setup with the GOB-38 findings in Elizabethkingia anophelis and shows how to troubleshoot signal quality without overinterpreting a single colorimetric result.

• UHRF1, Super-Enhancers, and Osteogenesis in SOP

  2026-09-28

  The study links UHRF1-associated DNA 5-methylcytosine (5-mC) changes to super-enhancer redistribution and impaired mesenchymal stem cell osteogenesis in senile osteoporosis. Its multi-omics and functional experiments implicate a TGM2-regulated autophagy axis and report that targeting the UHRF1–TGM2 pathway can rescue bone loss in a mouse model.

• Spirocyclic POM Analogues Target MmpL3 in TB

  2026-09-27

  This study reports spirocyclic phenyl oxazole methyl (POM) analogues and identifies compound 5c as a potent inhibitor of drug-susceptible and resistant Mycobacterium tuberculosis isolates. Mutant analysis implicates MmpL3 as its target, while docking, pharmacology, and cell-toxicity assessments provide supporting—but not definitive—evidence for further anti-tuberculosis development.

• Isochlorogenic Acid A Disrupts HBV Replication via HO-1

  2026-09-26

  The study finds that isochlorogenic acid A (ICAA) affects multiple stages of the hepatitis B virus life cycle, alongside HO-1 upregulation and changes in intracellular reactive oxygen species. Its results connect altered redox conditions with reduced viral products and impaired particle assembly, while leaving the causal steps to be tested more directly.

• T7 RNA Polymerase for RNA Stability Research

  2026-09-25

  T7 RNA Polymerase provides a defined way to generate RNA substrates for investigating how transcript production differs from transcript stability. This article connects in vitro transcription with recent findings on DDX21, NAT10, and ac4C-modified RNA in colorectal cancer—while clarifying what the enzyme can and cannot establish.

• Streptavidin-HyperFluor 647 Workflow Guide

  2026-09-25

  Use Streptavidin-HyperFluor 647 for sensitive far-red readout when your target carries biotin, from antibody staining to flow cytometry. For BmTyr proximity labeling, it is a complementary detection option only after adding a biotin handle; the study’s native azide-click workflow is biotin-free.

• ICAA Targets RIP3 to Reduce Cardiac Hypertrophy

  2026-09-24

  A 2026 study reports that isochlorogenic acid A (ICAA) attenuates angiotensin II- and pressure overload-induced cardiac hypertrophy by directly targeting RIP3 and suppressing downstream CaMKII signaling. Its findings distinguish this hypertrophic pathway from canonical RIP3–MLKL signaling and suggest a new mechanism for cardiovascular disease research, while leaving important questions about clinical relevance and dosing open.

• saRNA Influenza Vaccines: Dose and Durability

  2026-09-24

  A mouse study found that low-dose self-amplifying RNA vaccines generated durable antibody responses and protected against influenza B challenge where the tested conventional mRNA vaccine did not. The results point to platform- and subtype-dependent differences in dose sparing, while leaving important questions about human translation and comparative performance unresolved.

• Clasto-Lactacystin β-lactone in RIPK3 Assays

  2026-09-23

  Use Clasto-Lactacystin β-lactone to test whether proteasome activity contributes to RIPK3 loss during virus-induced necroptosis studies. This workflow pairs a fast pharmacological perturbation with genetic controls, protein-turnover readouts, and practical steps to separate pathway evidence from inhibitor toxicity.

• ALC-0159: From LNP Design to In Vivo Insight

  2026-09-23

  ALC-0159 is a PEG-conjugated lipid excipient that can support a more rigorous translational workflow for mRNA lipid nanoparticles. By pairing formulation control with PET-based measurement of encoded antigen expression, researchers can move beyond tracking delivery vehicles toward understanding where and how long biological activity occurs.

• Cardiogreen (Indocyanine Green) Workflow Guide

  2026-09-22

  Cardiogreen (Indocyanine green) bridges vascular imaging and controlled near-infrared light experiments, supporting cardiac output measurement, ophthalmic angiography, liver blood flow assessment, and photodynamic workflows. This practical guide emphasizes fresh-solution handling, optical controls, mechanistic readouts, and troubleshooting for reproducible research.

• p-Cresyl sulfate: Assays for Uremic Injury

  2026-09-22

  Build reproducible p-Cresyl sulfate exposure models that connect renal retention biology with endothelial, vascular, and biliary injury. This workflow emphasizes fresh-solution handling, albumin-aware dosing, orthogonal apoptosis measurements, and practical troubleshooting for translational assays.

• Silymarin: From Milk Thistle Extract to Translational Probe

  2026-09-21

  Silymarin is more than a familiar milk thistle extract: it is a chemically diverse flavonolignan mixture that can connect redox biology, cancer mechanisms, metabolism, and antiviral investigation. This thought-leadership guide shows how chemistry-aware design, mixture controls, and orthogonal validation can turn Silymarin into a more interpretable translational research probe.

8573 records 1/572 page Next 12345 下5页 Last page